4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-007662
Chief Operating Officer sold 24,500 shares at an average $4.23 ($103,708)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bisker-Leib Vered Chief Operating Officer | 2022-11-22 | Sale | −14,929 | $4.19 | $62,553 | 1,069,985 | D |
| Bisker-Leib Vered Chief Operating Officer | 2022-11-23 | Sale | −9,569 | $4.30 | $41,147 | 1,060,416 | D |
| Bisker-Leib Vered Chief Operating Officer | 2022-11-25 | Sale | −2 | $4.36 | $9 | 1,060,414 | D |
| Open-market sales · 24,500 sh · avg $4.23 · $103,708 | |||||||
Loading xslF345X03/ownership.xml…